SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis
Spiazzi BF, Piccoli GF, Wayerbacher LF, et al.
Diabetes Res Clin Pract. 2024:111933.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Spiazzi BF, Piccoli GF, Wayerbacher LF, et al.
Diabetes Res Clin Pract. 2024:111933.
Leggi
Adare AF, Tiyare FT, Marine BT
BMC Endocr Disord. 2024;24(1):252.
Leggi
Makam S, Stein LK, Dhamoon MS
Stroke. Pub. online 22 Nov 2024.
Leggi
Bi Y, Li M, Liu Y, et al.
N Engl J Med. Pub. online 16 Nov 2024.
Leggi
Zile MR, Borlaug BA, Kramer CM, et al.
Circulation. Pub. online 18 Nov 2024.
Leggi
Ostrominski JW, Højbjerg Lassen MC, Claggett BL, et al.
Eur Heart J. 2024:ehae780.
Leggi
Hirsch IB, Draznin B, Buse JB, et al.
Diabetes Care. 2024:dc241779.
Leggi
Galderisi A, Sims EK, Evans-Molina C, et al.
Diabetologia. Pub. online 19 Nov 2024.
Leggi
Lee YJ, Hong BK, Yun KH, et al.
JAMA Cardiol. 2024:e243911.
Leggi
Kreienkamp RJ, Shields BM, Pollin TI, et al.
Diabetes Care. 2024:dc241565.
Leggi